Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale Blanks Robert sold 38,000 shares at $5.96 ($226,290)
  2. 4 Grant or award Director acquired 12,204 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 11,023 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Director acquired 17,322 shares (grant or award)
  8. 4 Planned sale President & CEO sold 35,000 shares at $6.65 ($232,743)
  9. 4 Open-market sale Chief Medical Officer sold 145,000 shares at an average $7.12 ($1,033,080)
  10. 4 Open-market sale Chief Development Officer sold 17,872 shares at $7.00 ($125,104)
  11. 4 Planned sale President & CEO sold 7,500 shares at $6.72 ($50,390)
  12. 4 Open-market sale Chief Medical Officer sold 4,794 shares at $7.81 ($37,446)
  13. 4 Open-market sale Chief Development Officer sold 7,053 shares at $7.81 ($55,091)
  14. 4 Open-market sale Chief Commercial Officer sold 6,703 shares at $7.81 ($52,357)
  15. 4 Open-market sale Chief Financial Officer sold 5,167 shares at $7.81 ($40,359)
  16. 4 Open-market sale President & CEO sold 31,484 shares at $7.81 ($245,922)
  17. 4 Open-market sale GRAMMER ELIZABETH A sold 6,927 shares at $7.81 ($54,107)
  18. 4 Open-market sale Felsch Robert Ora sold 3,485 shares at $7.81 ($27,221)
  19. 4 Open-market sale Blanks Robert sold 4,855 shares at $7.81 ($37,922)
  20. 4 Planned sale President & CEO sold 3,000 shares at $7.99 ($23,970)

Page 8 of 35 · 690 filings